Today Simulations Plus, Inc. (SLP) Stock Reaches 52-Week High

May 17, 2018 - By Christine McCrea

Simulations Plus, Inc. (NASDAQ:SLP) Logo

Investors sentiment decreased to 1.56 in Q4 2017. Its down 0.50, from 2.06 in 2017Q3. It worsened, as 6 investors sold Simulations Plus, Inc. shares while 19 reduced holdings. 14 funds opened positions while 25 raised stakes. 5.50 million shares or 1.31% more from 5.43 million shares in 2017Q3 were reported.
Comml Bank Of Montreal Can holds 0% in Simulations Plus, Inc. (NASDAQ:SLP) or 6,516 shares. Schwab Charles Investment Mgmt Incorporated invested in 19,500 shares or 0% of the stock. Crawford Investment Counsel invested in 0.19% or 377,580 shares. Manufacturers Life Insurance The reported 9,378 shares stake. Bnp Paribas Arbitrage owns 2,260 shares. Acadian Asset Management Ltd Liability Corp owns 0% invested in Simulations Plus, Inc. (NASDAQ:SLP) for 22,399 shares. Dimensional Fund Lp holds 0% or 437,405 shares in its portfolio. Barclays Pcl accumulated 1,734 shares. Blackrock reported 0% of its portfolio in Simulations Plus, Inc. (NASDAQ:SLP). Rice Hall James & Assocs Ltd Limited Liability Company accumulated 84,679 shares or 0.05% of the stock. Cove Street Limited Liability Corporation invested in 70,000 shares. Deutsche Bancorp Ag reported 24,583 shares. Pnc Financial Serv Gru holds 0% or 36,540 shares. Legal & General Group Public Ltd, United Kingdom-based fund reported 2,134 shares. Moreover, Wells Fargo & Communications Mn has 0% invested in Simulations Plus, Inc. (NASDAQ:SLP).

Since February 26, 2018, it had 0 buys, and 4 sales for $938,452 activity. 2,991 shares were sold by KNEISEL JOHN ROBERT, worth $52,766.

The stock of Simulations Plus, Inc. (NASDAQ:SLP) hit a new 52-week high and has $20.68 target or 8.00 % above today’s $19.15 share price. The 9 months bullish chart indicates low risk for the $331.79 million company. The 1-year high was reported on May, 17 by Barchart.com. If the $20.68 price target is reached, the company will be worth $26.54M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 1.29% or $0.25 during the last trading session, reaching $19.15. About 24,776 shares traded. Simulations Plus, Inc. (NASDAQ:SLP) has risen 29.91% since May 17, 2017 and is uptrending. It has outperformed by 18.36% the S&P500.

Analysts await Simulations Plus, Inc. (NASDAQ:SLP) to report earnings on July, 9. They expect $0.13 earnings per share, 0.00 % or $0.00 from last year’s $0.13 per share. SLP’s profit will be $2.25 million for 36.83 P/E if the $0.13 EPS becomes a reality. After $0.11 actual earnings per share reported by Simulations Plus, Inc. for the previous quarter, Wall Street now forecasts 18.18 % EPS growth.

Another recent and important Simulations Plus, Inc. (NASDAQ:SLP) news was published by Businesswire.com which published an article titled: “Simulations Plus to Present at the Needham Emerging Technology Conference on May 16, 2018” on May 15, 2018.

Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company has market cap of $331.79 million. The firm offers GastroPlus, which simulates the absorption, pharmacokinetics , and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It has a 40.66 P/E ratio. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor.

Simulations Plus, Inc. (NASDAQ:SLP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: